Geron Newsroom

Needham Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsDec 13 09:31 ET · Ratings

Sector Update: Health Care Stocks Steady Premarket Friday

MT NewswiresDec 13 09:17 ET

Express News | Needham Reiterates Buy on Geron, Maintains $6 Price Target

BenzingaDec 13 09:05 ET

Buy Rating on Geron Driven by EU Approval Prospects and Strategic Commercialization of Rytelo

TipRanksDec 13 09:05 ET · Ratings

Geron's Rytelo Secures European Medicines Agency Committee's Approval Recommendation

MT NewswiresDec 13 07:30 ET

Geron Says Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Approval Of RYTELO (Imetelstat) For Treatment Of Adult Patients With Transfusion-dependent (TD) Anemia Due To Very Low, Low Or Intermediate Risk...

BenzingaDec 13 06:38 ET

Express News | Geron Announces Positive Chmp Opinion for Rytelo™ (Imetelstat) for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk Mds

ReutersDec 13 06:36 ET

Stifel Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsDec 11 08:31 ET · Ratings

Geron (GERN) Gets a Buy From Stifel Nicolaus

TipRanksDec 11 07:45 ET · Ratings

TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsDec 11 06:31 ET · Ratings

Geron (GERN) Receives a Buy From TD Cowen

TipRanksDec 11 05:48 ET · Ratings

Is Geron Corporation (GERN) the Best NASDAQ Penny Stock to Buy Right Now?

Yahoo FinanceDec 11 02:15 ET

Geron Announces Result From IMproveMF Study at ASH

TipRanksDec 10 09:20 ET

Geron Announces Phase 1 Findings From Two-Part IMproveMF Study Suggesting Tolerability Of RYTELO In Combination With Ruxolitinib As Frontline Therapy In Patients With Myelofibrosis Presented At ASH; In The Dose Escalation Part 1 Of The Study, No...

BenzingaDec 10 09:09 ET

Express News | Geron Announces New Imerge Analyses Presented at Ash Suggesting Clinical Activity of Rytelo™ (Imetelstat) in Patients With Lower-Risk Mds Regardless of Type or Number of Prior Therapies

ReutersDec 10 09:00 ET

Express News | Geron Announces Phase 1 Findings From Two-Part Improvemf Study Presented at Ash Suggesting Tolerability of Rytelo™ (Imetelstat) in Combination With Ruxolitinib as Frontline Therapy in Patients With Myelofibrosis

ReutersDec 10 09:00 ET

Geron Analyst Ratings

BenzingaDec 10 07:17 ET · Ratings

H.C. Wainwright Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsDec 10 06:31 ET · Ratings

Scotiabank Reaffirms Their Buy Rating on Geron (GERN)

TipRanksDec 9 07:50 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Geron (GERN), Merus (MRUS) and C4 Therapeutics (CCCC)

TipRanksDec 9 07:50 ET · Ratings